US Stock MarketDetailed Quotes

VRDN Viridian Therapeutics

Watchlist
  • 14.580
  • +0.770+5.58%
Close May 2 16:00 ET
930.53MMarket Cap-2745P/E (TTM)

Viridian Therapeutics Key Stats

Viridian Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

72.00K

-31.43%
EPS(YoY)

-1.35

-19.47%

Strong Buy

May 2, 2024

Viridian Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 123.580K--
--2024/Q1-- / 121.500K--
--2023/Q472.000K / 154.180K--
--2023/Q372.000K / 101.420K--
--2023/Q272.000K / 195.550K--
May 9, 20232023/Q198.000K / 0.000--
Mar 8, 20232022/Q4105.000K / 457.600K--
Nov 14, 20222022/Q31.195M / 260.000K--
Aug 15, 20222022/Q2256.000K / 231.710K--
May 12, 20222022/Q1216.000K / 253.500K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 123.580K--
--2024/Q1-- / 121.500K--
--2023/Q472.000K / 154.180K--
--2023/Q372.000K / 101.420K--
--2023/Q272.000K / 195.550K--
May 9, 20232023/Q198.000K / 0.000--
Mar 8, 20232022/Q4105.000K / 457.600K--
Nov 14, 20222022/Q31.195M / 260.000K--
Aug 15, 20222022/Q2256.000K / 231.710K--
May 12, 20222022/Q1216.000K / 253.500K--

Unlock Free Earnings Estimates

Viridian Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 2, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg